End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,120 KRW | +0.49% |
|
-12.07% | -1.61% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
100.0
%
| 860 | 100.0 % | 177 | 100.0 % | -79.46% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 860 | 100.0 % | 177 | 100.0 % | -79.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hae-Jin Kim
FOU | Founder | 64 | 19/02/01 |
Eun-Jung Moon
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Nam-Deuk Jeon
BRD | Director/Board Member | 59 | - |
Tae-Oh Lee
BRD | Director/Board Member | 67 | - |
Tae-Geun Kim
AUD | Comptroller/Controller/Auditor | 62 | 28/03/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tae-Oh Lee
BRD | Director/Board Member | 67 | - |
Hae-Jin Kim
FOU | Founder | 64 | 19/02/01 |
Eun-Jung Moon
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Nam-Deuk Jeon
BRD | Director/Board Member | 59 | - |
Byung-Chul Lee
BRD | Director/Board Member | 60 | - |
Jae-Hak Shim
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,827,840 | 6,347,060 ( 58.62 %) | 0 | 58.62 % |
Stock B | 0 | 467,566 | 0 | 0 |
Company contact information
![address Ensol Biosciences Inc.(A140610)](https://cdn.zonebourse.com/static/address/120975136.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-1.61% | 37.97M | |
+21.22% | 127B | |
+24.38% | 117B | |
+25.44% | 27.67B | |
-18.72% | 20.33B | |
-15.17% | 16.79B | |
-15.98% | 15.63B | |
+12.87% | 14.84B | |
-47.10% | 14.65B | |
+57.69% | 14.43B |
- Stock Market
- Equities
- A140610 Stock
- Company Ensol Biosciences Inc.